Login / Signup
Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases.
Richard Felwick
J R F Cummings
Published in:
Alimentary pharmacology & therapeutics (2017)
Keyphrases
</>
image quality
dual energy
computed tomography
contrast enhanced
ulcerative colitis
positron emission tomography
magnetic resonance imaging